---
document_datetime: 2023-09-21 17:50:21
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ziagen-epar-all-authorised-presentations_en.pdf
document_name: ziagen-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7545781
conversion_datetime: 2025-12-29 23:30:34.17876
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging    | Content   | Pack size                               |
|------------------|-------------------|------------|-----------------------|---------------------------|------------------------|-----------|-----------------------------------------|
| EU/1/99/112/001  | Ziagen            | 300mg      | Film-coated tablet    | Oral use                  | Blister (PVC/alu foil) |           | 60 tablets                              |
| EU/1/99/112/002  | Ziagen            | 20mg/mL    | Oral solution         | Oral use                  | Bottle (HDPE)          | 240 mL    | 1 bottle + 1 dosing syringe + 1 adapter |